Neoadjuvant TherapyChemotherapy, AdjuvantCombined Modality TherapyNeoplasm StagingTreatment OutcomeRadiotherapy, AdjuvantAntineoplastic Combined Chemotherapy ProtocolsChemoradiotherapy, AdjuvantBreast NeoplasmsEsophagectomyAdjuvants, ImmunologicRectal NeoplasmsFluorouracilDisease-Free SurvivalTaxoidsEsophageal NeoplasmsEpirubicinAdenocarcinomaPrognosisDoxorubicinCisplatinAntineoplastic AgentsChemoradiotherapyNeoplasm Recurrence, LocalFreund's AdjuvantSurvival RateCyclophosphamideReceptor, erbB-2Survival AnalysisRetrospective StudiesAntineoplastic Agents, HormonalDeoxycytidineAnthracyclinesLymphatic MetastasisPaclitaxelSarcomaAntibodies, Monoclonal, HumanizedReceptors, EstrogenNeoplasm, ResidualPancreatic NeoplasmsCystectomyKaplan-Meier EstimateTumor Markers, BiologicalFollow-Up StudiesPositron-Emission TomographyProspective StudiesOrganoplatinum CompoundsCarcinoma, Squamous CellFluorodeoxyglucose F18PancreatectomyPredictive Value of TestsMastectomy, SegmentalPancreaticoduodenectomyReceptors, ProgesteroneBiomarkers, PharmacologicalCarcinoma, Ductal, BreastNomogramsPreoperative CareLeucovorinAdjuvants, PharmaceuticMuscle NeoplasmsTomography, X-Ray ComputedEsophagogastric JunctionDrug Administration ScheduleOsteosarcomaNitrilesCarcinoma, LobularMastectomyTumor BurdenProstatectomyBridged CompoundsMethotrexateVinblastineTime FactorsCarcinomaRadiopharmaceuticalsKi-67 AntigenMultivariate AnalysisLymph Node ExcisionTamoxifenTriazolesAndrogen AntagonistsUrinary Bladder NeoplasmsImmunohistochemistrySoft Tissue NeoplasmsNeoplasm MetastasisCarcinoma, Pancreatic DuctalBone NeoplasmsMultimodal ImagingAxillaCarboplatinNeoplasm InvasivenessAntimetabolites, AntineoplasticNeoplasm GradingGoserelinFlutamideRadiotherapy DosageAntibodies, MonoclonalAromatase InhibitorsLung Neoplasms